Ambagon Therapeutics
Donna Olivia Debets is currently a Senior Scientist Proteomics at Ambagon Therapeutics since October 2022. Prior to this, Donna Olivia worked as a Scientist Proteomics at Universiteit Utrecht from January 2017 to February 2023. Donna's expertise lies in the application and development of quantitative proteomics techniques to study breast cancer signaling. Throughout their career, Donna Olivia has gained experience as a Research Intern at the University of Cambridge and as a Student Assistant at Universiteit Utrecht. Donna holds a Master of Science (MSc) in Pharmacy from Utrecht University, where Donna Olivia also obtained their Bachelor's degree in Pharmacy.
This person is not in any offices
Ambagon Therapeutics
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.